Acute human defibrillation performance of a subcutaneous implantable cardioverter-defibrillator with an additional coil electrode

被引:4
|
作者
Yap, Sing -Chien [7 ,8 ]
Oosterwerff, Erik F. J. [6 ]
Boersma, Lucas V. A. [1 ,2 ]
van der Stuijt, Willeke [2 ]
Lenssen, Anneke [4 ]
Hahn, Stephen J. [5 ]
Knops, Reinoud E. [3 ]
机构
[1] Erasmus MC, Cardiovasc Inst, Thorax Ctr, Dept Cardiol, Rotterdam, Netherlands
[2] Isala Klin, Dept Cardiol, Zwolle, Netherlands
[3] St Antonious Ziekenhuis, Dept Cardiol, Nieuwegein, Netherlands
[4] Univ Amsterdam, Med Ctr, Dept Cardiol, Amsterdam, Netherlands
[5] Boston Sci, Amsterdam, Netherlands
[6] Boston Sci CRM, St Paul, MN USA
[7] Flevo Hosp, Almere, Netherlands
[8] Erasmus MC, Dept Surg, Doctor Molenwaterpl 40, NL-3015 GD Rotterdam, Netherlands
关键词
Defibrillation; Subcutaneous; Human; Electrodes; Implantable cardioverter-defibrillator; OUTCOMES; TRIAL; ICD;
D O I
10.1016/j.hrthm.2023.08.009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background The subcutaneous implantable cardioverter-defibrillator (S-ICD) delivers 80 J shocks from an 8 cm left-parasternal coil to a 59 cm(3) left lateral pulse generator (PG). A system that defibrillates with lower energy could significantly reduce PG size. Computer modeling and animal studies suggested that a second shock coil either parallel to the left-parasternal coil or transverse from the xiphoid to the PG pocket would significantly reduce the defibrillation threshold.Objective The purpose of this study was to acutely assess the defibrillation efficacy of parallel and transverse configurations in patients receiving an S-ICD.Methods Testing was performed in patients receiving a conventional S-ICD system. Success at 65 J was required before investigational testing. A second electrode was temporarily inserted from the xiphoid incision connected to the PG with an investigational Y-adapter. Phase 1 (n = 11) tested the parallel configuration. Phase 2 (n = 21) tested both parallel and transverse configurations in random order.Results This study enrolled 35 patients (28 males (80%); mean age 51 +/- 17 years; left ventricular ejection fraction 40% +/- 15%; body mass index 26 +/- 4 kg/m(2); prior myocardial infarction 46%; congestive heart failure 49%; cardiomyopathy 63%). Compared to the conventional S-ICD system, mean shock impedance decreased for both parallel (69 +/- 15 Omega vs 86 +/- 20 Omega; n = 33; P < .001) and transverse (56 +/- 14 Omega vs 81 +/- 21 Omega; n = 20; P < .001) configurations. Shock success rates at 20, 30, and 40 J were 55%, 79%, 97%, and 25%, 70%, 90% for parallel and transverse configurations, respectively. Defibrillation threshold testing was well tolerated with no serious adverse events.Conclusion Adding a second shock coil, particularly in the parallel configuration, significantly reduced the impedance and had a high likelihood of defibrillation success at energies <= 40 J. This may enable the development of a smaller S-ICD.
引用
收藏
页码:1649 / 1656
页数:8
相关论文
共 50 条
  • [21] Subcutaneous implantable cardioverter-defibrillator in a young woman
    Calvagna, Giuseppe Mario
    Ceresa, Fabrizio
    Patane, Salvatore
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2014, 175 (02) : E30 - E32
  • [22] An Entirely Subcutaneous Implantable Cardioverter-Defibrillator REPLY
    Bardy, Gust H.
    Smith, Warren M.
    Grace, Andrew A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (16): : 1577 - 1578
  • [23] IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR LEAD TECHNOLOGY - IMPROVED PERFORMANCE AND LOWER DEFIBRILLATION THRESHOLDS
    LANG, DJ
    HEIL, JE
    HAHN, SJ
    LINDSTROM, CC
    DERFUS, DL
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 1995, 18 (03): : 548 - 559
  • [24] Subcutaneous array to transvenous proximal coil defibrillation as a solution to high defibrillation thresholds with implantable cardioverter defibrillator distal coil failure
    Avitall, B
    Oza, SR
    Gonzalez, R
    Avery, R
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2003, 14 (03) : 314 - 315
  • [25] Implantable cardioverter-defibrillator lead performance
    Maisel, William H.
    Kramer, Daniel B.
    CIRCULATION, 2008, 117 (21) : 2721 - 2723
  • [26] Novel intravascular defibrillator: Defibrillation thresholds of intravascular cardioverter-defibrillator compared to conventional implantable cardioverter-defibrillator in a canine model
    Sanders, William E., Jr.
    Richey, Mark W.
    Malkin, Robert A.
    Masson, Stephen C.
    Ransbury, T. J.
    Urtz, Mark W.
    Ideker, Raymond E.
    HEART RHYTHM, 2011, 8 (02) : 288 - 292
  • [27] Defibrillation testing during implantation of the subcutaneous implantable cardioverter-defibrillator: a necessary standard or becoming redundant?
    W. van der Stuijt
    A. B. E. Quast
    R. E. Knops
    Netherlands Heart Journal, 2020, 28 : 122 - 127
  • [28] Successful defibrillation testing in patients undergoing elective subcutaneous implantable cardioverter-defibrillator generator replacement
    de Veld, Jolien A.
    Pepplinkhuizen, Shari
    van der Stuijt, Willeke
    Quast, Anne-Floor B. E.
    Nordkamp, Louise R. A. Olde
    Kooiman, Kirsten M.
    Wilde, Arthur A. M.
    Smeding, Lonneke
    Knops, Reinoud E.
    EUROPACE, 2023, 25 (07):
  • [29] Successful defibrillation verification in subcutaneous implantable cardioverter-defibrillator recipients by low-energy shocks
    Biffi, Mauro
    Ziacchi, Matteo
    Angeletti, Andrea
    Castelli, Andrea
    Massaro, Giulia
    Martignani, Cristian
    Lovecchio, Mariolina
    Valsecchi, Sergio
    Diemberger, Igor
    CLINICAL CARDIOLOGY, 2019, 42 (06) : 612 - 617
  • [30] CHRONIC DEFIBRILLATION THRESHOLD TESTING IN PATIENTS UNDERGOING SUBCUTANEOUS IMPLANTABLE CARDIOVERTER-DEFIBRILLATOR GENERATOR CHANGE
    Patel, Raj
    Shahab, Ahmed
    Broman, Michael
    Aziz, Zaid
    Beaser, Andrew D.
    Upadhyay, Gaurav A.
    Kannan, Arun
    Jameria, Zenith
    Chen, Andrew
    Ozcan, Cevher
    Tung, Roderick
    Nayak, Hemal M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 538 - 538